Nasdaq - Delayed Quote USD

PGIM Jennison Health Sciences A (PHLAX)

30.61
-0.40
(-1.29%)
At close: May 9 at 8:04:23 PM EDT

Top 10 Holdings (50.74% of Total Assets)

SymbolCompany% Assets
Eli Lilly and Company 14.60%
UnitedHealth Group Incorporated 5.66%
Vertex Pharmaceuticals Incorporated 4.85%
argenx SE 4.47%
AstraZeneca PLC 4.18%
Neurocrine Biosciences, Inc. 3.68%
Bristol-Myers Squibb Company 3.58%
Boston Scientific Corporation 3.32%
CVS Health Corporation 3.31%
Danaher Corporation 3.07%

Sector Weightings

SectorPHLAX
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Overall Portfolio Composition (%)

Cash 2.96%
Stocks 97.04%
Bonds 0.00%
Others 0.00%
Preferred 0.00%
Convertible 0.00%

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

Equity Holdings

Average PHLAX Category Average
Price/Earnings 0.03 24.55
Price/Book 0.2 5.28
Price/Sales 0.4 2.06
Price/Cashflow 0.05 17.54
Median Market Cap 54,163.15 34,862.81
3 Year Earnings Growth 12.84 32.48

Bond Holdings

Performance & Risk

YTD Return -9.86%
5y Average Return 7.24%
Rank in Category (ytd) 69
% Rank in Category (ytd) --
Beta (5Y Monthly) 0.56
Morningstar Risk Rating

Fund Overview

Category Health
Fund Family PGIM Investments
Net Assets 1.46B
YTD Return -3.47%
Yield 0.80%
Morningstar Rating
Inception Date Jun 30, 1999

Fund Summary

The fund seeks investments whose prices will increase over time. It normally invests at least 80% of its investable assets in equity and equity-related securities of companies within the health sciences sector, such as pharmaceutical companies, biotechnology companies, medical device manufacturers, healthcare service providers and health maintenance organizations (HMOs) and other companies that derive at least 50% of their assets, revenues or profits from operations in the healthcare sector.

Related Tickers